Investment Firm ADIA Set to Pump $200 Million into Meril
Abu Dhabi Investment Authority Backs Indian MedTech Leader Meril
The Abu Dhabi Investment Authority (ADIA), one of the world’s largest sovereign wealth funds, has made a strategic investment of USD 200 million in Meril, a leading Indian medical device company. This investment values Meril at approximately USD 6.6 billion [1][2][4][5].
Founded in 2006 and headquartered in Vapi, Gujarat, Meril is a global innovator in medical technology with a focus on clinically advanced solutions across multiple specialties, including cardiovascular, orthopaedic, diagnostic, Endo-Surgery, and robotic surgery domains [1][5].
ADIA’s investment aims to support Meril in accelerating its product innovation pipeline, expanding manufacturing capabilities, and scaling its international presence. This partnership aligns with India's national goals of boosting domestic production of medical devices and reducing reliance on imports, thereby improving healthcare accessibility and affordability within the country [1].
The transaction is subject to regulatory approval by the Competition Commission of India (CCI) [3]. The investment includes both newly issued shares of Meril and a purchase of an existing approximately 3.06% stake from Bilakhia Holdings Pvt Ltd [3].
Meril's commitment to innovation is evident in its portfolio of 200+ technology platforms and its robust in-house global R&D ecosystem. This has enabled the company to lead in global clinical research and education [6]. Meril's next-generation innovations include the Myval Transcatheter Heart Valve (THV) series, MyClip Transcatheter Edge-to-Edge Repair (TEER) system, and the MISSO Surgical Robotic System [7].
In addition to its focus on innovation, Meril is committed to sustainability, quality, and global impact. The company operates state-of-the-art, vertically integrated, and globally certified manufacturing and R&D facilities across a 100-acre sustainable MedTech campus [8]. Meril also operates 12+ global training academies, empowering over 10,000 healthcare professionals annually [9].
The investment by ADIA values Meril at an enterprise value of USD 6.6 billion, making it one of the most valuable medical device companies in India. Post this investment, Meril will be backed by two globally recognized investors, ADIA and Warburg Pincus [1][4].
For more information about Abu Dhabi Investment Authority (ADIA), visit www.adia.ae. For more information about Meril, visit www.merillife.com.
[1] Meril Life Sciences Raises USD 200 Million from ADIA [2] Abu Dhabi Investment Authority Invests USD 200 Million in Meril Life Sciences [3] ADIA Invests USD 200 Million in Meril Life Sciences [4] ADIA and Warburg Pincus to Invest USD 200 Million in Meril Life Sciences [5] Meril Life Sciences: Overview and Investment by ADIA [6] Meril Life Sciences: R&D and Innovation [7] Meril Life Sciences: Next-Generation Innovations [8] Meril Life Sciences: Sustainability [9] Meril Life Sciences: Global Training Academies
- The strategic investment of USD 200 million by the Abu Dhabi Investment Authority (ADIA) into Meril, a leading Indian medical device company, is aimed at accelerating product innovation, expanding manufacturing capabilities, and scaling international presence, aligning with India's goals of boosting domestic production in healthcare and sustainability.
- Meril's innovative portfolio of over 200 technology platforms, supported by a robust in-house global R&D ecosystem, has enabled the company to lead in global clinical research and education, positioning it as a global innovator in medical technology.
- Meril's commitment to sustainability is reflected in its state-of-the-art, globally certified manufacturing and R&D facilities operated on a 100-acre sustainable MedTech campus, and its 12+ global training academies empowering over 10,000 healthcare professionals annually.
